In Les Ulis, Seqens succeeds Novartis for the CellForCure factory, specialist in biomedicines
2023-11-27 11:00:00 The CellForCure bioproduction plant in Les Ulis (Essonne) has a future. Founded by LFB in 2013 then acquired by Novartis in 2019, this strategic site for the production of biomedicines in France is changing hands again. On November 27, 2023, Seqens formalized the purchase of the site, effective from December 1, which will … Read more